Patients should be aware that cognitive dysfunction can delay recovery in major depressive disorder

At ECNP 2022, Dr Charlotte Emborg discussed how people with major depressive disorder (MDD) often have insight into their condition but recovery may be slowed down by cognitive dysfunction and/or hampered by substance abuse problems. Discussion is needed to help a patient understand the need to remain on medication to more fully return to how they were prior to MDD onset. Treatment considerations should take into account both clinical efficacy and side-effects and, in drug-naïve patients especially, psychoeducation regarding potential short- and long-term side-effects is key to help maintain drug adherence. Cognitive function may take longer to respond to medication than mood disorder symptoms of MDD and patients need counselling to understand the impact of such symptoms and how time is needed for all aspects of MDD to resolve.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country